| Dr Matthew A Hofkens, DO | |
|
5715 Memorial Ave N, Oak Park Heights, MN 55082 | |
| (651) 439-8807 | |
| (651) 439-0232 |
| Full Name | Dr Matthew A Hofkens |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 18 Years |
| Location | 5715 Memorial Ave N, Oak Park Heights, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568605210 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 51369 (Minnesota) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 51369 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infinite Health Collaborative Pa | 1052225042 | 772 |
News Archive
The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.
Employment policy is also health policy according to a University of British Columbia study that found that workers experienced higher mortality rates if they didn't have access to social protections like employment insurance and unemployment benefits.
Scientists from Nanyang Technological University, Singapore have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
› Verified 8 days ago
| Entity Name | Group Health Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.
Employment policy is also health policy according to a University of British Columbia study that found that workers experienced higher mortality rates if they didn't have access to social protections like employment insurance and unemployment benefits.
Scientists from Nanyang Technological University, Singapore have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
› Verified 8 days ago
| Entity Name | Infinite Health Collaborative Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164474250 PECOS PAC ID: 1052225042 Enrollment ID: O20040209000574 |
News Archive
The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.
Employment policy is also health policy according to a University of British Columbia study that found that workers experienced higher mortality rates if they didn't have access to social protections like employment insurance and unemployment benefits.
Scientists from Nanyang Technological University, Singapore have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
› Verified 8 days ago
| Entity Name | Tria Orthopaedic Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518273085 PECOS PAC ID: 3173570561 Enrollment ID: O20110310000999 |
News Archive
The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.
Employment policy is also health policy according to a University of British Columbia study that found that workers experienced higher mortality rates if they didn't have access to social protections like employment insurance and unemployment benefits.
Scientists from Nanyang Technological University, Singapore have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew A Hofkens, DO 4200 Dahlberg Dr Ste 300, Golden Valley, MN 55422-4841 Ph: (952) 512-5600 | Dr Matthew A Hofkens, DO 5715 Memorial Ave N, Oak Park Heights, MN 55082 Ph: (651) 439-8807 |
News Archive
The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.
Employment policy is also health policy according to a University of British Columbia study that found that workers experienced higher mortality rates if they didn't have access to social protections like employment insurance and unemployment benefits.
Scientists from Nanyang Technological University, Singapore have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
› Verified 8 days ago
Dr. Thomas Jason Cesarz, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5803 Neal Ave N, Oak Park Heights, MN 55082 Phone: 651-439-8807 Fax: 651-439-0232 |